Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Second trial begins for DTI-136 in the treatment of liver cancer

June 18, 1998

Abarelix poised to enter phase III clinical development

June 18, 1998

Irish research organization discovers MAO inhibitor with cytoprotective effects

June 18, 1998

Oncolym makes progress in phase II

June 18, 1998

P&U identifies potent distamycin derivatives with improved therapeutic indices

June 18, 1998

New dihydrofolate reductase inhibitors with antitumor and antiparasitic activities

June 17, 1998

Yissum discloses peptidomimetic protein farnesyltransferase inhibitors

June 17, 1998

Results from antiangiogenic cancer gene therapy reported

June 16, 1998

Taisho presents the topoisomerase II inhibitor NCA-0424

June 16, 1998

Tricyclic compounds inhibiting abnormal cell growth discovered at Schering-Plough

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...